LX6171 High Dose
LX6171.1-201-AAMI
Phase 2 small_molecule completed
Quick answer
LX6171 High Dose for Age-Related Memory Disorders is a Phase 2 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEXICON PHARMACEUTICALS, INC.
- Indication
- Age-Related Memory Disorders
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed